Skip to content
DefDex

Federal award

SIO2 MEDICAL PRODUCTS INC

W911NF2030003

Assistance

Obligated and Ceiling

Obligated (net)
$196,748,752.37
Potential value
—
Current value
—
Gross positive obligations
$207,639,748.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
SIO2 MEDICAL PRODUCTS INC · MCUKF6KCCN84
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
SIO2 MEDICAL PRODUCTS INC · MCUKF6KCCN84
Awarding agency
Department of Defense · sub-agency 9763 · office S0140A
Funding agency
Department of Defense · sub-agency 2100
Assistance listing (CFDA)
CFDA 12.360
FAIN
W911NF2030003
Award type code
11
Actions
16 · Jun 5, 2020 to Oct 8, 2024
Why it is listed
a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)

Open this award on USAspending →

Action History16

Award actions
DateFYModAction typeObligationCompany in company totals
Oct 8, 2024FY2025A00003B1$0.00
—
Oct 7, 2024FY2025A00004B1$0.00
—
May 21, 2024FY2024ARZ998B1$0.00
—
Nov 29, 2023FY2024P00009B1−$10,890,995.63
—
Jan 10, 2023FY2023P00008B1$0.00
—
Jul 28, 2022FY2022P00007EX$0.00
—
Nov 15, 2021FY2022P00006EX$0.00
—
Jul 26, 2021FY2021P00005FX$64,639,748.00
—
Jun 10, 2021FY2021P00004EX$0.00
—
Nov 20, 2020FY2021A00002EX$0.00
—
Aug 31, 2020FY2020A00001EX$0.00
—
Aug 19, 2020FY2020ARZ999EX$0.00
—
Aug 18, 2020FY2020P00003EX$0.00
—
Jul 14, 2020FY2020P00002EX$0.00
—
Jun 18, 2020FY2020P00001EX$0.00
—
Jun 5, 2020FY20200A1$143,000,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.